BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 16375647)

  • 21. Chemotherapy for muscle-invasive bladder cancer in the perioperative setting: current standards.
    Dreicer R
    Urol Oncol; 2007; 25(1):72-5. PubMed ID: 17208143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
    deVere White RW; Katz MH; Steinberg GD
    J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
    [No Abstract]   [Full Text] [Related]  

  • 23. Combining surgery and chemotherapy for invasive bladder cancer: current and future directions.
    Amiel GE; Lerner SP
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):281-91. PubMed ID: 16445380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy of advanced bladder cancer.
    Hall RR; Roberts JT
    Prog Clin Biol Res; 1989; 303():525-31. PubMed ID: 2675009
    [No Abstract]   [Full Text] [Related]  

  • 25. Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
    Mak RH; Zietman AL; Heney NM; Kaufman DS; Shipley WU
    BJU Int; 2008 Nov; 102(9 Pt B):1345-53. PubMed ID: 19035903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.
    Izawa JI; Chin JL; Winquist E
    Can J Urol; 2006 Jun; 13 Suppl 3():48-53. PubMed ID: 16818012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Systemic chemotherapy of urothelial cancer].
    Wolff JM; Jakse G
    Urologe A; 1992 May; 31(3):W19-24. PubMed ID: 1615589
    [No Abstract]   [Full Text] [Related]  

  • 28. Bladder cancer.
    Gwynn ES; Clark PE
    Curr Opin Oncol; 2006 May; 18(3):277-83. PubMed ID: 16552241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of advanced urothelial cancer trials of the Eastern Cooperative Oncology Group.
    Dreicer R; Roth B; Wilding G;
    Cancer; 2003 Apr; 97(8 Suppl):2109-14. PubMed ID: 12673703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current developments in the medical treatment of advanced urothelial carcinoma of the bladder].
    Schmid SC; Gschwend JE; Retz M;
    Aktuelle Urol; 2014 Jan; 45(1):55-63; quiz 64-5. PubMed ID: 24500963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel agents for muscle-invasive and advanced urothelial cancer.
    Sonpavde G; Ross R; Powles T; Sweeney CJ; Hahn N; Hutson TE; Galsky MD; Lerner SP; Sternberg CN
    BJU Int; 2008 Apr; 101(8):937-43. PubMed ID: 18005203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of disseminated disease in the patient with bladder cancer.
    Perry JJ; Muss HB
    Urol Clin North Am; 1994 Nov; 21(4):661-72. PubMed ID: 7974898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma.
    Liu D; Plimack ER; Hoffman-Censits J; Garraway LA; Bellmunt J; Van Allen E; Rosenberg JE
    JAMA Oncol; 2016 Aug; 2(8):1094-6. PubMed ID: 27310333
    [No Abstract]   [Full Text] [Related]  

  • 34. Analysis of trials using chemotherapy for metastatic bladder cancer.
    Tannock IF
    Prog Clin Biol Res; 1988; 260():487-98. PubMed ID: 3283769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer.
    Pectasides D; Pectasides M; Economopoulos T
    Cancer Treat Rev; 2006 Oct; 32(6):456-70. PubMed ID: 16935429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status of chemotherapy for urothelial tract tumors.
    Sternberg CN; Scher HI
    Oncology (Williston Park); 1987 Jul; 1(5):41-50, 60. PubMed ID: 3079483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy followed by surgery: the case for a marker lesion.
    Denis L; D'Hont C; Hendrickx G; Keuppens F
    Prog Clin Biol Res; 1990; 353():195-201. PubMed ID: 2217419
    [No Abstract]   [Full Text] [Related]  

  • 38. Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy.
    Suttmann H; Kamradt J; Lehmann J; Stöckle M
    BJU Int; 2007 Dec; 100(6):1225-8. PubMed ID: 17979921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bladder cancer: management of advanced disease.
    Chong CD
    Tex Med; 1987 Feb; 83(2):51-4. PubMed ID: 3824246
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prognostic factors of urinary bladder carcinoma].
    vom Dorp F; Jaeger T; Schmidt K; Siffert W; Rübben H
    Urologe A; 2007 Sep; 46(9):1151. PubMed ID: 17641868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.